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Abstract Covalent complexes of nucleic acids and proteins are
widespread among viruses. Covalent complexes of RNA and
proteins are proposed to exist in eukaryotic cells. The goal of this
work was to obtain specific antibodies to the covalent linkage
unit (CLU) between virus RNA and protein to search cellular
RNA-protein complexes. Antibodies were generated by direct
immunization of a rabbit with the BSA-coupled EMC virus
RNA-VPg complex. By a dot-blot immunoassay and immuno-
fluorescent microscopy it was found that the antibodies
specifically recognize both EMC virus RNA-VPg and synthetic
CLU-containing compounds. Thus, a fraction of the antibodies
was directed to CLU.
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1. Introduction
Covalent complexes of nucleic acids (NA) and proteins (P)
are widespread among animal and plant viruses. The goal of
this work was to obtain antibodies speci¢c to the covalent
linkage unit (CLU) between RNA and protein VPg of picor-
naviruses. It is well known that the 5P-end uridylic acid of
picornaviral RNA is linked with VPg by a phosphodiester
bond via the unique tyrosine residue [1^4].
The inter-polymer phosphodiester linkage in the complex is
speci¢cally hydrolyzed by an ‘unlinking’ enzyme, whose activ-
ity was discovered in animal and plant cells [5^8]. One would
expect that there are unknown yet cellular RNA-protein co-
valent complexes ^ potential targets for the enzyme that struc-
turally resemble the picornaviral RNA-VPg. This type of nat-
ural compounds is di⁄cult to detect, and to date, few cellular
covalent (presumably) complexes of RNA and proteins have
been characterized [9^13]. The covalent complex of the tumor
suppresser p53 protein and 5.8S rRNA was isolated from rat
embryo ¢broblasts [9], this being the most exciting observa-
tion. The function of this complex is not quite clear yet, but
the multifunctional properties of the tumor suppresser protein
are well known ([9] and references therein). Thus, raising anti-
bodies to the RNA-VPg CLU of picornaviruses arouses con-
siderable interest both in a search for the cellular RNA-pro-
tein covalent complexes and in a study of the mechanism of
the picornavirus RNA replication.
In this work antibodies that recognize either the encepha-
lomyocarditis (EMC) virus RNA-VPg or CLU were generated
by direct immunization of a rabbit with the modi¢ed EMC
virus RNA-VPg. The antibodies were puri¢ed by chromatog-
raphy and characterized by a dot-blot assay and immuno-
£uorescent microscopy. It was found that they recognized
CLU in either the EMC virus RNA-VPg or synthetic N-Ac-
Tyr(O-pU-2P-NH2)OEt and N-Ac-Tyr(O-pT13C2)OEt speci¢-
cally.
2. Materials and methods
O-Phosphotyrosine and BSA (fraction V), 2-cyanoethyl-N,N-diiso-
propylchlorophosphoramidite and N-benzoyl-L-tyrosine ethyl ester
were from Sigma, pU from Calbiochem, BrCN activated Sepharose
from Pharmacia, 5P-O-(4,4P-dimethoxytrityl)-N-acyl-deoxynucleoside-
3P-O-P-2-cyanoethyl-N,NP-diisopropylphosphoramidites from Perkin
Elmer, dichloroacetic acid, dichloromethane and 1H-tetrazole from
Aldrich and N-ethyldiisopropylamine from Fluka.
EMC virus propagation and RNA-VPg isolation were done as in
[3], except that the ascites cells were suspended (2U107/ml) and in-
fected (multiplicity of infection was 0.1, two cycle infection for 16 h)
in Eagle’s minimum essential medium. Actinomycin D was omitted.
Tobacco mosaic virus was kindly provided by Dr. V.K. Novikov,
TMV RNA was isolated by phenol deproteinization.
The N-terminal dodecapeptide of EMCV VPg was synthesized by
Dr. Yu. Semiletov.
2.1. Synthesis of RNA-VPg antigens, immunization of a rabbit and
antibody isolation
The antigen RNA-VPg, conjugated with BSA (AG I) was obtained
by glutaric dialdehyde coupling of EMC virus RNA-VPg with BSA.
With this purpose 17 Wl of 1% SDS, 52 Wl of BSA (1 mg/ml) and 9 Wl
of 1 M NaHCO3 (pH 10.3) were added to 500 Wg of EMCV RNA-
VPg. 9 Wl of 5% glutaric dialdehyde was added to the cocktail ob-
tained and the mixture was incubated for 30 min at 37‡C. The reac-
tion was stopped by fast chilling to 0‡C with the addition of NaBH4
(12 Wl, 20 mg/ml) and subsequent incubation for 3 h at 0‡C. The
resulting conjugate was precipitated with 11 Wl of 3 M acetate bu¡er
(pH 4.6) and 340 Wl of ethyl alcohol at 320‡C. The precipitate was
washed with 70% alcohol and vacuum dried. The antigen RNA-VPg
(AG II) was obtained using an identical procedure except that BSA
was omitted. A rabbit was injected intracutaneously with a 10 day
interval twice with 250 Wg of AG I dissolved in PBS and then six times
with 100 Wg of AG II.
The antiserum was fractionated by a sulfate ammonium salting out
of globulins [14]. The precipitated globulins were further fractionated
by DEAE chromatography [14], the immunoglobulins were character-
ized by UV spectrophotometry and SDS-PAG electrophoresis as in
[15]. The depletion of Abs with BSA was carried out using a home-
made BSA-BrCN-Sepharose column. A⁄nity-puri¢ed anti-BSA Abs
were eluted from this column. The Abs against the N-terminal
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dodecapeptide of EMCV VPg were also puri¢ed by a⁄nity chroma-
tography.
2.2. Analysis of antibody speci¢city
Nitrocellulose membranes BA 85 (Schleicher and Schuell), second-
ary goat anti-rabbit Abs conjugated with the colloidal gold and silver
enhancement system (Amersham) were used for immunochemical de-
tection of the substances.
Usually, 1^10 Wl of the samples were spotted by a microsyringe
onto membranes wetted with 20USSC. Nucleic acid composed sam-
ples were ¢xed by UV light at 254 nm (3U15 W UVB lamps, the
distance to the object was 7 cm, 4 min). The membranes were blocked
with 2% of Tween-20/PBS and washed in 0.025% Tween-20/PBS.
Then the membranes were incubated overnight at 4‡C in the PBS
solution of the primary Abs (A280W0.1), thereafter they were washed
with 0.025% Tween-20/PBS and incubated for 2 h at room temper-
ature with conjugates of the secondary Abs and colloidal gold. The
images were obtained by silver enhancing according to the manufac-
turer’s protocol. All immunochemical detections were repeated at least
twice.
2.3. Synthesis of Tyr-(5PPCO)-pN phosphodiesters mimicking the
CLU
dT13C2 (70 nM) was synthesized by the solid phase (35 mg LCAA-
CPG-dCBz, Millipore) phosphoramidite method [16] with a Biosearch
Model 8600 DNA synthesizer. After 5PO-DMTr had been cleaved, the
polymer was thoroughly washed with absolute dichloromethane and
acetonitrile. Subsequently, the oligodeoxynucleotide was treated with
a phosphorylating mixture (0.85 mmol 2-cyanoethyl-N,N-isopropyl-
chlorophosphoramidite and 1.1 mmol N-ethyldiisopropylamine in
1.5 ml of 1,2-dichloroethane) for 20 min at room temperature
(21‡C). The excess of reagents was washed out with absolute 1,2-di-
chloroethane and absolute acetonitrile. Phosphorylated oligodeoxynu-
cleotide on a solid support reacted with 0.57 mmol N-benzoyl-L-ty-
rosine ethyl ester and 0.45 mmol of 1H-tetrazole in 1 ml of acetonitrile
at room temperature for 40 min. The support was washed with ace-
tonitrile and the phosphoramidite group was oxidized by a standard
procedure [16]. Deprotection and cleavage of oligonucleotide were
achieved by treating with concentrated aqueous NH3 at 50‡C over-
night. The yield of ethyl ether of (N-Bz)Tyr-(5PPCO)-dT13C2 was
60%.
Synthesis of 5PPCO phosphodiester between Urd(2P-NH2) coupled
with the resin and N-benzoyl-L-tyrosine ethyl ester was carried out
analogously. The yield was about 30%. The structure of tyrosine de-
rivatives of (oligo)nucleotides was proved by spectrophotometry, RP
HPLC, TLC and amino acid analysis.
2.4. Immuno£uorescent microscopy of EMCV infected cells
CHO cells were plated in F10 medium supplemented with 10% fetal
calf serum and gentamicin (100 mg/ml) at 37‡C. The EMC virus
suspension was added (30 pfu/cell), the virus adsorption proceeded
at room temperature for 30 min, and the unsorbed virus was washed
out. The cells were incubated for 7 h at 37‡C and then ¢xed with
methanol at 320‡C. Immuno£uorescence staining was performed as
described in [14]. Secondary goat anti-rabbit immunoglobulins conju-
gated with tetramethylrhodamine isothiocyanate (Sigma) were used.
The preparations were examined with Photomicroscope-3 (Opton).
3. Results and discussion
3.1. Synthesis of antigens, rabbit immunization and antibody
isolation
Little or nothing has been reported regarding immunization
of animals with RNA directly, though autoimmune Abs
against cellular RNAs produced after some virus infections
are extended over many animal species (for review see [17]).
It is a matter of general experience that the immune response
to cell nucleic acids is complex and weak.
To increase the antigenic power of the RNA-VPg com-
pound and its resistance to cellular nucleases [18], and to
suppress its infectiousness which is important in the case of
mouse immunization (unpublished data), the natural virus
RNA-VPg complex was modi¢ed with dialdehyde and then
coupled with BSA. Aliphatic amino groups of VPg and amino
groups of heterocyclic nucleic bases are the ¢rst to interact
with aldehydes [19] and become cross-linked. To render modi-
¢cation irreversible, the reaction of RNA-VPg with dialde-
hyde was stopped by sodium borohydride treatment. As a
result of the coupling, the electrophoretic mobility of RNA-
VPg in 1% agarose dropped appreciably (data not shown). At
the last stages of the immunization, to increase the immune
response against RNA-VPg itself, AG II (see Section 2.1) was
used whereas BSA was omitted.
We have found that the resulting immunogenicity of AG I
and AG II was very low: even by the immunogold method a
speci¢c reaction with EMCV RNA-VPg was displayed by
1:25 dilution of the ¢nal antiserum only (data not shown).
Using immuno£uorescent microscopy, speci¢c immunostain-
ing of the EMCV infected cell was discovered with the same
serum diluted up to 500 times. Even though the ¢rst two
immunizations were carried out with AG I (in which RNA-
VPg is coupled with BSA) only, we found that the titer of the
BSA-speci¢c immunoglobulins in the serum was higher than
that of the RNA-VPg one by a factor of 25.
An electrophoretically pure fraction of IgG was obtained
(apparently, admixture of IgM was also detected) after sulfate
ammonium fractionation and DEAE cellulose chromatogra-
phy of immune serum. Then this preparation was depleted by
chromatography on the BSA Sepharose column to remove
immunoglobulins speci¢c to BSA. According to absorption
at 280 nm, at this step 96% of IgG was adsorbed onto the
BSA a⁄-column. The resulting preparation of Abs (Ab-1)
(those that were puri¢ed on DEAE cellulose and depleted
with BSA) was further used in the study.
3.2. Analysis of antibody speci¢city
Evidently, an immune response against the complex antigen
like EMC virus RNA-VPg results in the formation of Abs
with a wide range of speci¢city, among which are immuno-
globulins recognizing viral RNA ribotopes, epitopes of
EMCV VPg and, apparently, those of the CLU. To examine
the speci¢city of the Abs, two methods were chosen: mem-
brane immunochemical analysis and immuno£uorescent mi-
croscopy. The analysis of complex compounds like RNA-
VPg by dot immunochemistry on a membrane ¢lter represents
a certain technical problem because of the restrictions im-
posed by the capacity of the membrane. Our experience sug-
gests the use of the BA-85 (0.45 Wm) nitrocellulose membrane
(up to 3 pmol of EMCV RNA-VPg can be reproducibly ¢xed
by UV light at 254 nm onto V3 mm2 of the membrane) and
the immunogold detection system.
The results of analysis of the Ab-1 speci¢city are demon-
strated in Fig. 1. Data taken from di¡erent experiments are
accumulated in one picture. It is evident that the Ab-1 recog-
nized in any case EMCV RNA-VPg, TMV RNA, N-Ac-
Tyr(O-pU-2P-NH2)OEt, N-Ac-Tyr(O-pT13C2)OEt, dT13C2
and BSA (Fig. 1, 1st line). The reaction of Ab-1 with
EMCV RNA-VPg, TMV RNA and BSA was stronger than
with N-Ac-Tyr(O-pU-2P-NH2)OEt and N-Ac-Tyr(O-
pT13C2)OEt. The reaction of Ab-1 with dT13C2 was weaker
than with N-Ac-Tyr(O-pT13C2)OEt. One can notice that af-
¢nity puri¢ed Abs to BSA did not recognize any compounds
examined except BSA (Fig. 1, 4th line). The preimmune im-
munoglobulins also exhibited no speci¢c reaction with the
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antigens and ligands used (data not shown). Thus, Ab-1 in-
teracts speci¢cally with the viral nucleic acids and synthetic
CLU-containing compounds.
As mentioned earlier, the antiserum contained high quanti-
ties of Abs interacting with BSA. In spite of puri¢cation of
the Ab preparation against EMCV RNA-VPg by a⁄nity
chromatography on the BSA Sepharose column, reaction of
the puri¢ed Abs with BSA still remained visible (Fig. 1). An
addition (up to 20 Wg/ml) of BSA to this Ab preparation
substantially reduced its reaction with BSA, but not with
EMCV RNA-VPg (Fig. 1, 3rd line).
The reaction of Ab-1 with pure TMV RNA (Fig. 1) indi-
cates that Ab-1 contains anti-ribotope immunoglobulins. We
found, however, that titration of the Ab preparation by an
addition of TMV RNA up to 20 Wg/ml drastically restrained
the immune reaction with TMV RNA, but not with EMCV
RNA (Fig. 1, 2nd line). So, Ab-1 contained not only broadly
speci¢c anti-virus RNA Abs, but also Abs to either speci¢c
EMC virus RNA ribotopes or to VPg, or to CLU.
To identify the population of the immunoglobulins recog-
nizing the CLU, the interaction between the Ab-1 and N-Ac-
Tyr(O-pT13C2)OEt and N-Ac-Tyr(O-pU-2P-NH2)OEt was ex-
amined. A positive signal was obtained in all cases and, as
mentioned above, it was distinctly weaker when obtained with
dT13C2 (Fig. 1, 1st line). In the case of the CLU-mimicking
compound N-Ac-Tyr(O-pU-2P-NH2)OEt, the strength of the
signal correlated linearly with the ligand quantity in the range
of 3^300 pmol (data not shown). It is important to note that
the only common antigenic determinants shared by the RNA-
VPg complex and the synthetic model phosphodiesters of ty-
rosine and nucleotides are those which belong to the CLU. An
addition of O-pTyr or pU in V100 times molar excess over
N-Ac-Tyr(O-pU-2P-NH2)OEt to the Ab-1 preparation showed
no interference (data not shown). Thus, in the Ab-1 prepara-
tion obtained there is a fraction of immunoglobulins which
interact preferentially with the CLU.
To reveal conclusively the immunoglobulin population
against EMC virus RNA-VPg, CHO cells were infected with
the EMC virus and virus propagation was examined by im-
muno£uorescent microscopy (Fig. 2). It is interesting that the
background immunostaining of the mock-infected cells, as
well as early-infected ones (up to 3 h) was weak and di¡use,
FEBS 19749 26-1-98
Fig. 1. Interaction of Abs against EMCV RNA-VPg or against BSA with di¡erent ligands spotted onto the membrane. Horizontal lines of the
grid represent di¡erent antibodies, vertical rows represent di¡erent ligands, as indicated. Numbers under the spots are pmol of the ligands.
Empty squares are shaded.
Fig. 2. Immuno£uorescent microscopy of CHO cells infected with the EMC virus and immunostained either with antibodies against EMCV
RNA-VPg (A) or with antibodies to the synthetic N-terminal dodecapeptide of EMCV VPg (B) and preimmune serum (C). Uninfected cells are
indicated by arrows. Bar, 10 Wm.
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regardless of a high content of cellular RNAs in the cyto-
plasm. It con¢rms that Ab-1 were not broadly speci¢c anti-
RNA Abs. Maximal immunostaining of infected CHO cells
was attained after 7 h infection. Similar results were obtained
during a study of the EMC virus infection dynamics in mouse
L ¢broblasts [20]. As a control, the infected cells were also
displayed with the Abs speci¢c to the synthetic N-terminal
dodecapeptide of EMC virus VPg (Fig. 2B), and a similar
immunostaining pattern was obtained. No speci¢c immuno-
staining of the infected cells was revealed with the preimmune
antiserum or the immunoglobulins (Fig. 2C). Taking into con-
sideration the data obtained, we conclude that in the Ab
preparation under study there is a population of immunoglob-
ulins speci¢cally recognizing EMC virus RNA-VPg.
In connection with the above, it is of interest to obtain Abs
against the mentioned synthetic models, mimicking the CLU,
and to study all cross-reactions between these Abs and the
ligands. The preliminary studies showed that antiserum to
N-Ac-Tyr(O-pT13C2)OEt cross-reacts with EMC virus RNA-
VPg [20]. We believe that the Abs against EMC virus RNA-
VPg and the above synthetic models might be useful in a
search for yet unknown cellular RNA-protein covalent com-
plexes and in studying the mechanism of the EMC virus in-
fection.
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